Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
417
-
Total 13F shares, excl. options
-
168M
-
Shares change
-
+8.52M
-
Total reported value, excl. options
-
$15.6B
-
Value change
-
+$821M
-
Put/Call ratio
-
1.23
-
Number of buys
-
236
-
Number of sells
-
-149
-
Price
-
$92.52
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q3 2016
492 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q3 2016.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 417 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168M shares
of 192M outstanding shares and own 87.72% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (20.2M shares), VANGUARD GROUP INC (12.2M shares), SANDS CAPITAL MANAGEMENT, LLC (10.2M shares), FMR LLC (10.1M shares), JENNISON ASSOCIATES LLC (9.7M shares), PRIMECAP MANAGEMENT CO/CA/ (7.11M shares), BAKER BROS. ADVISORS LP (4.81M shares), BlackRock Institutional Trust Company, N.A. (4.13M shares), BlackRock Fund Advisors (4.05M shares), and JPMORGAN CHASE & CO (3.7M shares).
This table shows the top 417 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.